An educational workshop on the early detection of prostate cancer

Australian Family Physician

Volumn 34, Issue 10, 2005, Pages 889-891

  Steginga, Suzanne K ^a   Pinnock, Carole ^b   Baade, Peter D ^c   Jackson, Claire ^d   Green, Anita ^e   Preston, John ^f   Heathcote, Peter ^g   McAvoy, Brian ^h  

^a Australia   (Australia)

^b REPATRIATION GENERAL HOSPITAL   (Australia)

^c VIERTEL CENTRE FOR RESEARCH IN CANCER CONTROL   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e Brisbane N Div of General Practice   (Australia)

^f Greenslopes Urology Clinic   (Australia)

^g PRINCESS ALEXANDRA HOSPITAL   (Australia)

^h National Cancer Control Initiative   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGED; ARTICLE; AUSTRALIA; BLOOD; EDUCATION; GENERAL PRACTICE; HUMAN; INFORMED CONSENT; MALE; MASS SCREENING; MEDICAL EDUCATION; MIDDLE AGED; PATIENT EDUCATION; PROSTATE TUMOR; RISK ASSESSMENT;

AGED; AUSTRALIA; EDUCATION, MEDICAL, CONTINUING; FAMILY PRACTICE; HUMANS; INFORMED CONSENT; MALE; MASS SCREENING; MIDDLE AGED; PATIENT EDUCATION; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RISK ASSESSMENT;

EID: 33644835439     PISSN: 03008495     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Harris R, Lohr KN. Screening for prostate cancer: an update of the evidence for the US Preventative Services Task Force. Ann Intern Med 2002;137:917-29.
2. The Royal Australian College of General Practitioners. Guidelines for preventive activities in general practice. Melbourne: Royal Australian College of General Practitioners, 2005.
3. The Cancer Council Australia. National Cancer Prevention Policy 2004-2006. NSW: The Cancer Council Australia, 2004.
4. Weller D, Pinnock C, Alderman C, et al. Screening for prostate cancer: Update of the 1996 AHTAC Report. Draft Final Report. Adelaide: Department of Evidenced Based Care and General Practice. Flinders University of South Australia, September 6, 1998.
5. Catalona WJ. Informed consent for prostate specific antigen screening. Urology 2003;61:17-9.
6. Baade PD, Coory MD, Aitken JF. International trends in prostate cancer mortality: the decrease is continuing and spreading. Cancer Causes Control 2004;15:237-41.
7. Bill-Axelson A, Holmberg L, Ruutu M, et al. Radical prostatectomy versus watchful waiting in early prostate cancer. New Engl J Med 2005;352:1977-84.
8. Johansson J, Andren O, Andersson S, et al. Natural risk and history of early, localised prostate cancer. JAMA 2004;291:2713-9.
9. Slevin TJ, Donnelly N, Clarkson JP, English DR, Ward JE. Prostate cancertesting: behavior, motivation and attitudes among Western Australian men. Med J Austw 1999;171:185-8.
10. Smith DP, Armstrong BK. Prostate specific antigen testing in Australia and association with prostate cancer incidence in New South Wales. Med J Aust 1998;169:17-20.
11. Steginga SK, Occhipinti S, McCaffrey J, Dunn J. Men's attitudes to prostate cancer and seeking prostate specific antigen testing. J Cancer Educ 2001;16:42-5.
12. Weller D, Pinnock C, Silagy C, Hiller JE, Marshall VR. Prostate cancer testing in SA men: influence of sociodemographic factors, health beliefs and LUTS. Aust NZ J Public Health 1998;22:400-2.
13. Australian Health Technology Advisory Committee. Prostate cancer screening. Canberra: Australian Government Publishing Service, 1996.
14. The Urological Society of Australasia. PSA screening for prostate cancer, 1999. Available at: www.urosoc.org.au/info/psa.html Accessed 19 May 2005.
15. Wilkinson S, Chodak G. Informed consent for prostate specific antigen screening. Urology 2003;61:2-4.
16. Woolf SH, Krist AH, Johnson RE, Stenborg PS. Unwanted control: how patients in the primary care setting decide about screening for prostate cancer. Patient Educ Couns 2005;56:116-24.
17. Talcott JA. What patients should be told before agreeing to a blood test that could change their lives. Urology 2003;61:7-9.
18. Bird S. Discussing benefits and risks with patients PSA testing. Aust Fam Physician 2004;33:266-7.
19. Dunn IB, Kirk D. Legal pitfalls in the diagnosis of prostate cancer. BJU Int 2000;86:304-7.
20. Steginga SK, Occhipinti S, Gardiner RA, Yaxley J, Heathcote P. Making decisions about treatment for localised prostate cancer. BJU Int 2002;89:255-60.
21. O'Connor AM, Rostom A, Fiset V, et al.Decision aids for patients facing health treatment or screening decisions: systematic review.BMJ 1999;319:731-734
22. Pinnock C. PSA testing in general practice: can we do more now? Med J Aust 2004;180:379-81.
23. Harris RP, Flood AB, Berge V, Coates RJ. Screening for prostate cancer: sharing the decision slide set. National Center for Chronic Disease Prevention and Health Promotion. Available at: www.cdc.gov/cancer/prostate/screening/slide_index.htm Accessed 20 May 2005.
24. Baade PD, Steginga SK, Pinnock C, Aitken JF. Communicating prostate cancer risk: what should we be telling our patients. Med J Aust 2005;182:472-5.